Cannabidiol in Children With Refractory Epileptic Encephalopathy
Status:
Active, not recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and tolerability of a cannabidiol-enriched Cannabis Herbal
Extract in a small group of children with refractory epileptic encephalopathy. The dosage of
Cannabis Herbal Extract will be gradually increased over a four month time period.